Search research articles
Contact Us
Filters
Showing results (211-220 of 249) with videos related to
Page
of 25
Sort By:
Bone Marrow Transplantation
|
September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations
R Greco, A Ruggeri, D P McLornan, et al.
Trials
|
February 6, 2021
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
G Moreno-González, A Mussetti, A Albasanz-Puig, et al.
Bone Marrow Transplantation
|
April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011
J R Passweg, H Baldomero, M Bregni, et al.
Bone Marrow Transplantation
|
March 19, 2014
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
J R Passweg, H Baldomero, C Peters, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Transplantation and Cellular Therapy
|
November 28, 2022
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
M L Schoettler, E Carreras, B Cho, et al.
Bone Marrow Transplantation
|
November 7, 2019
Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document
J L Bueno, A Alegre, O López-Villar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Blood
|
December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
B B Björkstrand, P Ljungman, H Svensson, et al.
Trials
|
May 20, 2020
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
J Laporte-Amargos, C Gudiol, M Arnan, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 249) with videos related to
Sort By:
Page
of 25
Bone Marrow Transplantation
|
September 9, 2025
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations
R Greco, A Ruggeri, D P McLornan, et al.
Trials
|
February 6, 2021
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
G Moreno-González, A Mussetti, A Albasanz-Puig, et al.
Bone Marrow Transplantation
|
April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011
J R Passweg, H Baldomero, M Bregni, et al.
Bone Marrow Transplantation
|
March 19, 2014
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
J R Passweg, H Baldomero, C Peters, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Transplantation and Cellular Therapy
|
November 28, 2022
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
M L Schoettler, E Carreras, B Cho, et al.
Bone Marrow Transplantation
|
November 7, 2019
Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document
J L Bueno, A Alegre, O López-Villar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)
R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Blood
|
December 15, 1996
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation
B B Björkstrand, P Ljungman, H Svensson, et al.
Trials
|
May 20, 2020
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
J Laporte-Amargos, C Gudiol, M Arnan, et al.
Page
of 25